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While the relationship between increased physical activity and cognitive ability has been
conjectured for centuries, only recently have the mechanisms underlying this relationship
began to emerge. Convergent evidence suggests that physical activity offers an affordable
and effective method to improve cognitive function in all ages, particularly the elderly who
are most vulnerable to neurodegenerative disorders. In addition to improving cardiac and
immune function, physical activity alters trophic factor signaling and, in turn, neuronal
function and structure in areas critical for cognition. Sustained exercise plays a role
in modulating anti-inflammatory effects and may play a role in preserving cognitive
function in aging and neuropathological conditions. Moreover, recent evidence suggests
that myokines released by exercising muscles affect the expression of brain-derived
neurotrophic factor synthesis in the dentate gyrus of the hippocampus, a finding that
could lead to the identification of new and therapeutically important mediating factors.
Given the growing number of individuals with cognitive impairments worldwide, a better
understanding of how these factors contribute to cognition is imperative, and constitutes
an important first step toward developing non-pharmacological therapeutic strategies to
improve cognition in vulnerable populations.
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INTRODUCTION
Man has sought to better understand the relationship between
a healthy body and mind for centuries. Exploring this relation-
ship during the pre-Socratic era, the Greek philosopher Thales
of Miletus (624–546 B.C.) declared that a happy man is one
that possessed a healthy body, a resourceful mind, and a docile
nature. Hippocrates (ca. 460–370 B.C.) deployed ancient science,
philosophy, and craft knowledge to produce the first systematic
Abbreviations: AD, Alzheimer’s disease; BBB, blood brain barrier; BDNF,
brain-derived neurotrophic factor; CRP, C-reactive protein; CNS, central
nervous system; CSF, cerebrospinal fluid; CXCL8, chemokine (CXC Motif)
ligand 8; XCL12, chemokine (CXC Motif) ligand 12; CXCL8R1, CXC
chemokine receptor 1; CXCL8R2, CXC chemokine receptor 2; DG, den-
tate gyrus; DGCs, dentate granule cells; ERRα, estrogen-related receptor α;
FNDC5, fibronectin type III domain containing 5; GCs, glucocorticoids; IGF-
1, Insulin-like growth factor 1; IL-6, interleukin 6; IL-8, interleukin 8; NGF,
nerve growth factor; NT-3, neurotrophin-3; NT4/5, neurotrophin-4/5; NTs,
neurotrophins; NE-ergic, nor-epinephrinergic; PD, Parkinson’s disease; PGC-
1α, peroxisome proliferator-activated receptor-gamma coactivator protein-
1alpha; rTMS, repetitive transcranial magnetic stimulation; ROS, reactive
oxygen species; SNP, single nucleotide polymorphism; Trk, tropomyosin
related kinase; TrkB, tropomyosin related kinase B belonging to receptor
tyrosine kinase family; TNF, tumor necrosis factor; UCP, uncoupling protein;
UTR, untranslated region.
explanations of human behavior and the body, focusing on both
states of health and illness. Later on, Plato (424/423–348/347 B.C.)
emphasized the importance of physical exercise for developing
the mind. He suggested the harmonious perfection of the body,
mind, and psyche could be achieved through physical exercise.
Echoing these sentiments, Roman poet Decimus Iunius Iuvenalis
(late 1st and early 2nd century A.D.) penned the phrase “Mens
sana in corpore sano” and, in so doing, articulated his belief that
a sane mind resided within a sound body. Diogenes expanded
upon these ideas by emphasizing that diet also contributes to
mental and physical prowess. Swiss-German physician Parceleus
(1493–1541) advocated for the holistic view treatment of diseases,
believing that consideration of the human mind is an integral
part of the holistic treatment of disease. As these ideas continued
to evolve at the end of the 19th century, the concept of holism
began to espouse the notion that stress and mental states have
a critical impact upon physical health. Implicit to this concep-
tualization is the idea that the mind and body are one entity
and stressful mental states adversely affect bodily health. Rec-
ognizing this, Joseph Pilates (1883–1967), a well-known athlete
and author, articulated his belief that achieving a balanced mind
and body required more than the absence of disease. Paramount
to Pilates conceptualization of wellness was the idea of balance
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between one’s mind, body, and spirit. Today, modern tools and
technologies have been deployed to understand the inextricable
relationship between mind and body and, in turn, are elucidating
the molecular and cellular mechanisms by which physical exercise
alters one important dimension of the mind: cognitive function.
Here we describe current knowledge on the effects of physical
activity on cognitive function and the cellular and molecular
mechanisms that underlie this relationship. Initially, an overview
of the putative mechanisms linking physical activity, cognition,
and the subsystems subserving cognitive function prefaces a more
intense focus on the neurotrophin signaling hypothesis. This will
be followed by a description of studies in both human and animal
models that implicate brain-derived neurotrophic factors (BDNF)
in these molecular and cellular processes. Finally, cautionary notes
regarding the deleterious effects of extreme physical activity are
proffered and suggestions for clinical intervention then flank the
discussion.
PUTATIVE MECHANISMS UNDERLYING THE RELATIONSHIP
OF PHYSICAL ACTIVITY AND COGNITIVE FUNCTION
Numerous studies have reported a robust relationship between
high levels of physical activity, hippocampal size, and cognitive
measures. Studies in the elderly have shown a direct correlation
between increased levels of physical activity and improved cog-
nition, with increases in hippocampal volume following exercise
(Erickson and Kramer, 2009), supporting the idea that physical
activity leads to anatomical and physiological alterations in the
brain. Studies in patients with schizophrenia have demonstrated
direct correlations between increased levels of physical activity,
increased hippocampal volume, and enhanced spatial memory
(Pajonk et al., 2010). Similarly, studies in healthy individuals have
demonstrated that high levels of physical exercise are associated
with increased hippocampal volume, increased cerebral blood
flow, enhanced spatial memory, and reduced brain tissue loss
(Colcombe et al., 2003; Pajonk et al., 2010). Although most
studies have been performed in adults, a number of studies in
school children clearly demonstrate positive correlations between
physical activity and academic performance as well (Bass et al.,
2013). Thus the benefits of physical activity on cognition appear
to be widespread across all age groups. While the dynamic cellular
and molecular cascades that underlie the association between
physical activity and cognitive function have yet to be fully eluci-
dated, four main hypotheses have been proposed to explain these
mechanisms: the cardiovascular, immunologic, neuroendocrine,
and neurotrophic signaling hypothesis.
CARDIOVASCULAR EFFECTS
The cardiovascular benefits of sustained physical activity include
improved exercise capacity, alterations in lipid profiles, reduc-
tions in obesity indices, increased rates of heart recovery and
variability, reduced resting pulse, and improved blood rheology
and hemodynamics (Vuori et al., 2013). Moreover, adequate
levels of physical activity are vital for improved small vessel
condition (Schmidt et al., 2013), increased cerebral blood flow,
and nutrient delivery (Swain et al., 2003). Together, the afore-
mentioned factors are thought to contribute to improved brain
health. In support of this idea, Colcombe et al. (2003) reported
increased levels of physical activity were inversely correlated with
reductions in gray and white matter loss, particularly in the
prefrontal, superior parietal, and temporal cortices (Colcombe
et al., 2003). Similarly, rodent studies have demonstrated that
running exercise lead to improvements in vascular perfusion and
angiogenesis in the motor cortex, alterations that were restricted
to the motor regions of the cerebral cortex. Other studies have
suggested that motor skill training increases synaptogenesis in
corresponding regions, while automatic, repetitive motor activ-
ities do not (Kleim et al., 1996). For example, motor learning
independent of physical activity leads to significant increases in
synaptogenesis in the Purkinje neurons in the cerebellum while
physical activity independent of motor learning leads to angio-
genesis in this region (Black et al., 1990). While cross sectional
studies on the relationship between cardiovascular fitness and
cognitive function have revealed weak correlations between the
two parameters (Hillman et al., 2005), strong and reproducible
positive correlations have been consistently revealed in the elderly,
suggesting that cardiovascular correlations are stronger when
there is a need to restore physical activity to basal threshold
levels (Lautenschlager et al., 2008). The idea that the benefits
derived from exercise stem from restorative effects of improved
cardiovascular function seems plausible given that aged indi-
viduals accrue cognitive deficits over time. In aggregate, these
findings suggest that physical activity is an important modulator
of cognition across the lifespan, but that the contribution of
cardiovascular fitness for sustaining healthy cognitive function
increases with age by impacting central and peripheral cellular
processes.
IMMUNOLOGICAL EFFECTS
Physical activity results in increased levels of pro-inflammatory,
anti-inflammatory cytokines, cytokine inhibitors and chemokines
depending upon the intensity and duration of such exercise.
The immunological benefits of sustained physical activity include
overall enhancement of immune function and anti-inflammatory
processes. The importance of the role of exercise in inducing
anti-inflammatory effects is underscored by the fact that chronic
inflammation has been linked etiologically to cognitive impair-
ment, cardiovascular diseases, and neurodegenerative disorders
including Alzheimer’s disease (AD) and Parkinson’s disease (PD;
Gleeson et al., 2011). Multiple studies have shown that indi-
viduals who regularly participate in physical activity appear to
have fewer viral and bacterial infections (DiPenta et al., 2004;
Kohut and Senchina, 2004), a lower incidence of systemic low-
grade inflammation (Stewart, 2002; Colbert et al., 2004), and
a lower incidence of neurodegeneration and cognitive decline
(Cotman et al., 2007). Investigating the effects of exercise on
immune function, Kohut et al. (2006) studied older adults par-
ticipating in aerobic or flexibility exercise for 10 months and
found a significant reduction in plasma levels of interleukin
6 (IL-6), interleukin 8 (IL-8), C-reactive protein (CRP), and
tumor necrosis factor (TNF), linking physical activity to anti-
inflammatory processes in the central nervous system (CNS).
Similarly, seventeen cross-sectional studies evaluated by Woods
et al. (2006) reported an inverse correlation between physi-
cal activity and CRP levels. Moreover, brief exercise in young
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adolescent males has been shown to significantly increase a
chemokine protein called chemokine (CXC Motif) ligand 12
(CXCL12) [formerly known as stromal cell-derived factor 1],
an important factor involved in angiogenesis (Zaldivar et al.,
2007).
While chronic exercise leads to a reduction in chronic inflam-
mation, acute exercise appears to promote a proinflammatory
release of cytokines. Performing a meta-analysis, Ploeger et al.
(2009) analyzed 19 studies that investigated the effects of acute
and chronic exercise on inflammation. They found that individ-
uals diagnosed with type I diabetes mellitus, cystic fibrosis, and
chronic obstructive pulmonary disease demonstrated an elevated
inflammatory response after participation in a single bout of
exercise, whereas patients diagnosed with chronic heart failure
and type 2 diabetes mellitus demonstrated an attenuated systemic
inflammatory response after participation in chronic endurance
training programs. Since the beneficial effects of exercise on
cognition usually involves physical activity for a longer duration
such as weeks or months, a common mechanism underlying the
effects of exercise on cognition might be related to its effects on
inflammatory factors IL-6, IL-8, CXCL12, CRP, and TNF.
1) IL-6 is a pro-inflammatory cytokine released in the periph-
ery by T-cells, macrophages, fibroblasts, endothelial cells, and
osteoblasts (Burger, 2013). IL-6 plays a critical role in the
metabolic regulation of muscle cells and is released in response
to eccentric muscle contraction (Febbraio and Pedersen, 2002).
Notably, elevation of IL-6 levels has also been shown to be a risk
factor for dementia (Ravaglia et al., 2007).
While some studies report that moderate levels of aerobic
exercise lead to release of IL-6 from muscle, with circulating
levels increasing up to 100-fold for up to 1 h following partic-
ipation (Pedersen and Fischer, 2007). Yet several other reports
indicate such increases of 100 fold occur after a strenuous bout
of exercise such as that encountered when running a marathon.
Since IL-6 easily crosses the blood brain barrier (BBB; Banks
et al., 1994), it could impose significant functional alterations
on neurons and glial cells. Rodent studies have shown IL-6
mRNA and its receptor in pyramidal cells and dentate granule
neurons of the hippocampus. IL-6 is expressed constitutively in
multiple regions of the CNS that are involved in the mechanisms
regulating metabolic, cognitive function, and neuroendocrine
changes during physiological conditions (Schobitz et al., 1993).
Overexpression of IL-6 in astrocytes in mice led to neurodegener-
ative alterations and an age-dependent inability to acquire new
learning (Heyser et al., 1997). Thus, while strenuous exercise-
induced increases in IL-6 could result in inflammation in the
brain, a recent report shows that a combination of progressive
resistance training and protein enriched diet can reduce circu-
lating levels of IL-6 in the elderly (Daly et al., 2014), suggest-
ing the link between IL-6 levels and exercise requires further
investigation.
2) IL-8 or chemokine (CXC Motif) ligand 8 (CXCL8) belongs
to CXC family of chemokines and affects many aspects of the
immune system, including chemotactic effects on B and T lym-
phocytes. Additionally, IL-8 appears to promote local angiogene-
sis in muscle (Akerstrom et al., 2005). Receptors for IL-8 include
CXC chemokine receptor 1 (CXCL8R1) and CXC chemokine
receptor 2 (CXCL8R2) and are expressed on neurons, glia, and
endothelial cells of the BBB. IL-8 enhances neurotransmitter
release and inhibits induction of long-term depression in purkinje
cells (Giovannelli et al., 1998). Recent work supports the notion
that IL-8 might induce neuromodulatory effects. For example, it
has been shown that poor memory performance could be linked
to reduced serum levels of IL-8 in aged individuals (Baune et al.,
2008). Notably, IL-8 increases in response to high-intensity exer-
cise (Ostrowski et al., 2001; Nieman, 2003), but not for moderate
intensity exercise (Nieman et al., 2000; Chan et al., 2004).
3) CXCL12 (formerly known as SDF-1) is a pleiotropic
chemokine that participates in adaptive immune responses and
angiogenesis by recruiting endothelial progenitor cells from the
bone marrow (Salcedo and Oppenheim, 2003; Hill et al., 2004).
It has been shown that 3 weeks of freewheel training leads to
a significant increase in CXCL12 gene expression, protein levels,
and learning and memory in Tg2576 mouse models of AD
(Parachikova et al., 2008). CXCL12 is extensively expressed in the
CNS, with CXCL12 mRNA and protein having been detected in
cholinergic, dopaminergic, and AVP-ergic neurons in the brain
(Callewaere et al., 2008). Accordingly, Tg2576 mice overexpress-
ing mutant APP with Swedish mutation show a significant reduc-
tion in CXCL12 mRNA levels in the hippocampus (Parachikova
et al., 2008). The question of whether CXCL12 plays a role in
the pathophysiology of cognitive dysfunction has been partially
addressed by experiments showing that mice chronically treated
with CXCL12 antagonist (AMD3100) display significant deficits
in learning and memory, as evidenced by their failure in T-maze
and novel object recognition (Parachikova et al., 2008).
4) CRP is an acute-phase protein found in the blood, the levels
of which play a crucial role in the human immune system. It has
been shown that pyramidal neurons of the hippocampus cortical
regions express CRP (Yasojima et al., 2000). Interestingly, these
neurons show increased expression of CRP in people with AD (Bi
et al., 2012). CRP is involved in activation of the complement
system and is synthesized primarily in the liver, adipose tissue,
and vascular smooth muscle cells (Yasojima et al., 2000). The
data on the effects of exercise on CRP are inconsistent. Significant
reductions in CRP levels were noted in 11 out of 25 trials of
aerobic-based regimens. Furthermore, there were significant CRP
reductions associated with physical activity detected in 9 out of 18
adult studies, 4 of 10 child studies, and 1 out of 3 elderly studies
(Michigan et al., 2011).
5) TNF (formerly known as tumor necrosis factor-α) is
monocyte-derived cytokine that performs a variety of func-
tions in the neuroimmune system, including cell proliferation,
differentiation, and cytolysis. It has been shown that elevated
levels of TNF are a risk factor for AD in older adults (Tan
et al., 2007). Accordingly, a number of studies have linked
TNF to AD pathology. It has been shown that reducing the
expression of TNF in mouse models of AD leads to a sig-
nificant reduction in Aβ accumulation (Culpan et al., 2011).
Accordingly, a positive correlation has been found between the
serum levels of TNF and severity of AD dementia (Guerreiro
et al., 2007; Bonotis et al., 2008). Quantification of protein
and gene expression for TNF has shown significant increases in
the brain cortex in AD (Frankola et al., 2011), yet moderate
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exercise of 1 month has been shown to reduce levels of
TNF (Ambarish et al., 2012). Moreover, moderate exercise in
the healthy elderly has been shown to result in a significant
reduction in TNF gene expression in muscles (Lambert et al.,
2008).
Together, the aforementioned studies reveal the presence of
a link between exercise and the immune system and implicate
this system in many neurobiological processes that underlie
cognitive dysfunction, aging, and neurogeneration, extending
well beyond classical chemotactic functioning. Among the pro-
cesses implicated are neuromodulatory and neurotransmitter-like
effects along with direct and indirect regulation of neurogenesis.
TROPHIC FACTOR SIGNALING AND THEIR MODULATORS
Neurotrophins
Improved trophic factor signaling has been considered as the
most popular hypothesis to explain the positive effects of phys-
ical activity on cognition, with attention centering on the neu-
rotrophins (NTs). NTs are comprised of a closely related family of
polypeptides that regulate a variety of neuronal functions includ-
ing proliferation, survival, migration, and differentiation (Salehi
et al., 2003, 2004). The mammalian NTs include nerve growth
factor (NGF), BDNF, neurotrophin-3 (NT-3) and, neurotrophin-
4/5 (NT4/5). These factors are synthesized by target neurons,
initially in the form of pre-pro-protein. The biological actions of
NTs are mediated by binding to two different classes of receptor
systems, the low affinity P75NTR receptor and the tropomyosin
related kinase (Trk) family of high affinity tyrosine kinase recep-
tors (Curtis et al., 1995; Villanueva, 2013). Following binding to
their receptors, NTs are internalized along with their receptor
and transported via retrograde axonal transport to the cell soma
where they initiate multiple survival promoting effects within the
nucleus (Curtis et al., 1995; Figure 1).
Evolutionary studies suggest that early members of the NT
family evolved approximately 600 million years ago from a com-
mon gene, resulting in the sharing of a highly conserved six-
cysteine residue domain. Early duplications in the ancestral gene
led to the formation of the four members of the NT family (NGF,
BDNF, NT-3, and NT4/5). Comparative studies have revealed that
while certain members of this NT family have shown extensive
divergence (e.g., NGF), others remained largely conserved (e.g.,
BDNF). BDNF’s high rate of conservation suggests poor evolu-
tionary tolerance for divergence (Götz et al., 1992).
Among NTs, BDNF is the most widely expressed in the brain,
affecting neuronal survival, differentiation, axonal path-finding
(Reichardt, 2006), regulation of dendritic trafficking to postsy-
naptic densities (Nakata and Nakamura, 2007), protection against
neuronal death in the hippocampus (Pringle et al., 1996), and the
induction and maintenance of late phase long-term potentiation
(Korte et al., 1995). Treatment of postnatal hippocampal slice
cultures with BDNF has been shown to increase spine density in
the CA1 area of the hippocampus (Alonso et al., 2004). Moreover,
intrahippocampal injection of human BDNF in rats leads to
significant improvement in memory in these animals (Alonso
et al., 2002). These studies support the notion that BDNF is
critically important to the cellular and subcellular mechanisms
that underlie learning and memory. Importantly, it has been
demonstrated that plasma BDNF is indeed a reliable biomarker
for impaired memory in humans (Komulainen et al., 2008).
The synthesis of BDNF occurs primarily in the CNS, initially
as a precursor molecule consisting of 250 amino acid residues,
a length twice the size of mature BDNF (Götz and Schartl,
1994). This synthesis has been shown to occur in areas with a
prominence in cognitive function (e.g., hippocampus, frontal,
parietal, and entorhinal cortex areas). Notably, these areas have
been shown to synthesize BDNF and its high affinity TrkB
receptors or retrogradely transport it to distant regions in the
brain. Human gene expression studies have demonstrated that
central BDNF synthesis is highest in the cortex and hippocam-
pus, followed by the amygdala, basal forebrain, dorsal vagal
complex, hindbrain, and ventral tegmental area of the midbrain
(Salehi et al., 2006; Marosi and Mattson, 2014). TrkB receptor
mRNA expression is equally well distributed and partially follows
that of BDNF. Moreover, a number of brain regions containing
BDNF have the ability to retrogradely transport BDNF from
their projection areas. For example, while raphe nuclei in the
brainstem of rodents are devoid of significant BDNF mRNA,
serotonergic 5-HT-ergic neurons in these nuclei can retrogradely
transport BDNF to their cell bodies from their projection areas
including frontal cortex, occipital cortex, entorhinal cortex, and
amygdala (Mufson et al., 1999; Salehi et al., 2007). Similarly,
norepinephrinergic (NE-ergic) neurons of locus coeruleus receive
retrogradely BDNF from entorhinal cortex and frontal cortex. The
histaminergic neurons of supramamillary area can retrogradely
receive BDNF from the hippocampal formation and entorhinal
cortex.
BDNF is synthesized in the periphery by vascular endothelial
cells, T-cells, B cells, monocytes (Kerschensteiner et al., 1999;
Nakahashi et al., 2000) and skeletal muscles (Mousavi and Jasmin,
2006). Once released, BDNF can cross the BBB bi-directionally
(Pan et al., 1998), resulting in a direct relationship between BDNF
levels in plasma and the brain (Karege et al., 2002). While most of
the BDNF that is produced peripherally is released into circula-
tion, internalized, and stored in platelets, the BDNF produced by
muscles is used locally at the neuromuscular junction (Fujimura
et al., 2002; Matthews et al., 2009).
NTs play a vital role in the maintenance of the structural and
functional health of neurons that underlie cognition (including
those of the hippocampal formation, basal forebrain cholinergic
neurons, and NE-ergic neurons of the locus coeruleus). Evi-
dence for this lies in the fact that BDNF is expressed perva-
sively throughout the brain, readily crosses the BBB, significantly
impacts the structure and function of the hippocampal dentate
gyrus (DG) via its widely expressed TrkB receptors, and imposes a
negative feedback on FNDC5 synthesis (negative feedback). These
facts suggest that NTs play a crucial role in cognition and, in
conjunction with the evidence that links exercise with cognition,
makes it seem plausible that NTs may be significantly involved
in the mechanisms that underlie the positive effects of physical
activity on cognitive function.
Lessons from BDNF Polymorphism. The most widely studied
polymorphism in BDNF is the val66met substitution (Sanchez
et al., 2011), a genetic variant that appears to alter susceptibility
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FIGURE 1 | Schematic representation of BDNF release, binding to TrkB
receptors, and downstream events following internalization. BDNF
dimers bind to TrkB receptors and cause autophosphorylation of tyrosine
residues on the cytoplasmic domain of TrkB receptors, generating docking
sites for several intracellular proteins. In turn, the activation of the TrkB
receptors facilitate interactions with Shp2, Shc, and PLC-γmolecules and
effectuates the signaling cascades such as PLC/PKC, PI3K/Akt, Ras/Erk,
AMPK/ACC and NFB pathways. Signaling pathways involved in BDNF-TrkB
interactions include: (1) PLC-γ1 signaling: Phosphorylated TrkB receptors bind
to PLC-γ1 and lead to its’ activation. PLC-γ1 hydrolyses Phosphatidylinositol
(4,5) to generate IP3 and DAG. While IP3 promotes release of Ca2+ from
internal stores, DAG stimulates DAG-regulated protein kinase C isoforms. (2)
Ras-MAP/erk signaling: Phosphorylation of Trk receptors provides a
recruitment site for binding of the PTB domain of the adaptor protein, Shc.
Shc recruits the adaptor protein, Grb2, and complexes with SOS, an exchange
factor for Ras (and Rac). Activated Ras stimulates signaling through several
downstream pathways, including those mediated by PI3-kinases, Raf, and
p38MAP kinase. (3) PI-3 kinase signaling: Phosphatidylinositides are
generated by PI3-kinase and activate phosphatidylinositide-dependent protein
kinase (PDK-1). PDK-1 activates the protein kinase Akt (also known as PKB),
which then phosphorylates several proteins important in promoting cell
survival.
to neuropathology and response to physical activity. This single
nucleotide polymorphism (SNP) results in the substitution of
adenine for guanine at position 196 (G196A), resulting in an
amino acid substitution of valine to methionine at position 66 of
pro-BDNF protein. It seems likely that the val66met substitution
alters BDNF processing and, ultimately, BDNF-TrkB signaling.
Knowledge of this data has led to the suggestion that the val66met
substitution alters the rate of activity dependent BDNF release by
affecting proper folding and sorting into secretory vesicles and
by reducing intracellular distribution: within the Golgi apparatus,
BDNF is sorted into regulated (activity dependent) or constitutive
secretory pathways (Sanchez et al., 2011). Sortilin, a member
of vacuolar protein sorting 10 family, is highly enriched in the
Golgi apparatus and plays an important role in BDNF processing
through binding to the pro-domain region of BDNF (Chen et al.,
2005). The occurrence of the val66met substitution in this region
leads to a significant decrease in BDNF interaction with sortilin
(Chen et al., 2005), which contributes to the mis-sorting of BDNF
into the constitutive secretory pathway (Figure 2).
In neurons, BDNF is not exclusively synthesized in the somata;
rather, fragments of BDNF mRNA are generally transported
from the cell body to the dendrites for local synthesis (Horch,
2004). Initial BDNF gene expression results in the formation of
two types of BDNF mRNA, those with short 3′ untranslated
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FIGURE 2 | Schematic representation of possible mechanisms by
which val66met substitution in BDNF leads to failed
activity-dependent release of BDNF. Val66met substitution alters the
dynamics of interaction between BDNF and two important proteins:
(1) Sortilin, which is involved in intracellular sorting and pro-neurotrophin
signaling. Val66met substitution leads to reduction of BDNF interaction
with this protein, which results in mis-sorting into the constitutive
secretory pathway instead of activity-dependent release. (2) Translin is a
highly conserved protein involved in mRNA transport. An exon found in all
BDNF mRNA splice variants contains a specific translin-binding region,
which is essential for appropriate BDNF mRNA dendritic targeting. It has
been shown that val66met substitution diminishes BDNF mRNA
interaction with translin, which leads to reduced translocation of BDNF
mRNA to dendrites (Published from Sanchez et al., 2011).
region (UTR) and others with long 3′ UTR. The long 3′ UTR
of the BDNF mRNA is transported to the dendrites, whereas the
short 3′ UTR remains within the cell body (An et al., 2008). It
has been suggested that by reducing interaction with translin,
an mRNA binding protein, the G to A substitution in BDNF
gene leads to failed translocation of BDNF mRNA to dendrites
(Chiaruttini et al., 2009), reducing its intracellular distribution
and contributing to neuropathology. Indeed, the presence of
this SNP has been linked to the occurrence of depression in
elderly and adolescents, depression in individuals with AD, stroke,
anorexia nervosa, anxiety-related disorders, depressive episodes
in bipolar disorder, suicidal behavior, schizophrenia, and intro-
version (Kim et al., 2008; Terracciano et al., 2010). Hippocampal
volumetric alterations have also been linked to BDNF polymor-
phism (Terracciano et al., 2010). Using a meta-analysis of 399
healthy individuals, Hajek et al. (2012) reported a significant
reduction in bilateral hippocampal volume in met carriers. In
this extensive and longitudinal study in healthy individuals, these
authors found val2met substitution predicted the rate of decline
in skill task performance and reduction in hippocampal vol-
ume (Sanchez et al., 2011). To determine whether the BDNF
polymorphism could moderate the effects of physical activity
on cognition, Erickson et al. (2008) evaluated the performance
of 1,032 midlife volunteers on a battery of tests for memory,
learning, and executive processes and physical activity (Erickson
et al., 2008). They reported a robust relationship between the
BDNF val2met substitution and cognitive performance, with high
levels of physical activity ameliorating the deleterious effects
of the met allele on working memory performance, suggesting
that physical activity can modulate the effects of genetic alter-
ations and provide positive outcomes on cognition. Interest-
ingly, Bryan et al. (2013) demonstrated that the presence of
A-alleles in the BDNF polymorphism predicted poor compliance
with participation in a high demand physical activity regimen
(Bryan et al., 2013). In aggregate, these studies suggest a bidi-
rectional relationship between BDNF polymorphism and physical
activity.
Therefore, the incidence of SNPs should be taken into account
when considering the effects of physical activity on BDNF levels
and vice versa (Figure 3). Future studies should consider the
contribution of BDNF SNPs, particularly rs6265, through well-
designed protocols that account for both the population under
study and type of exercise administered.
BDNF, physical activity, and cognition. Numerous studies in
humans and animals have linked the modulation of BDNF with
physical activity and cognition. Studies have demonstrated the
intensity of exercise training is positively correlated with BDNF
plasma levels in young, healthy individuals (Ferris et al., 2007).
Resistance exercise has also been shown to elevate serum BDNF
levels in young individuals (Yarrow et al., 2010). Moreover, it has
been shown that moderate levels of physical activity in people
with AD significantly increased plasma levels of BDNF (Coelho
et al., 2014). While the source of the exercise-induced-BDNF
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increases has yet to be fully identified, it appears the increase
originates from both central and peripheral sources, with 70–80%
of circulating BDNF deriving from the brain and the remaining
levels deriving from peripheral sources (e.g., platelets, T-cells,
B cells, and monocytes; Rasmussen et al., 2009). In humans, it
has been shown that 4 h of rowing activity leads to increased
levels of plasma BDNF from the internal jugular (an indicator
of central release from the brain) and radial artery (an indica-
tor of peripheral release; Rasmussen et al., 2009). Seifert et al.
(2010) reported that basal release of BDNF increases following 3
months endurance training in young and healthy individuals, as
measured from the jugular vein. These trends are augmented by
rodent studies showing that endurance training leads to increased
synthesis of BDNF in the hippocampal formation (Neeper et al.,
1995, 1996). Similarly, a significant positive correlation exists for
levels of physical activity and BDNF mRNA expression in the
hippocampus in rats. Exercise induced upregulation of BDNF has
been noted in the perirhinal cortex (Hopkins and Bucci, 2010).
The levels of BDNF remain upregulated for up to 7 days following
endurance training (Berchtold et al., 2005). Widenfalk et al.
(1999) have also reported an increase in BDNF-TrkB signaling
after treadmill running (Widenfalk et al., 1999). Interestingly,
while both physical activity and cognitive training can improve
cognitive function, only physical activity can improve BDNF
levels in plasma, suggesting that the positive effects of physical
activity are mediated by BDNF (Langdon and Corbett, 2012).
The question that remains to be addressed is whether blocking
the effects of increased BDNF levels block the positive effects
of physical activity on cognition. This question has been partly
answered by studies showing that blocking the effects of BDNF
on TrkB receptors reduced the positive effects of physical activity
on cognitive function (Vaynman et al., 2004a,b, 2006).
Insulin-like growth factor
Insulin-like growth factor 1 (IGF-1) is an important trophic
factor for growth and metabolic reactions. High concentrations
of this 70 amino acid polypeptide chain are released by the liver
(Clemmons et al., 1995). Epithelial cells comprising the choroid
plexus contain IGF receptors, enabling IGF to enter the brain
through the CSF pathway (Carro et al., 2000). The main sources
of IGF-1 production include muscles, liver, and the brain. Cells
with an important role in IGF-1 production in the brain include
perivascular macrophages and microglia (Eliakim et al., 1997;
Carro et al., 2000). In addition, endothelial cells of the blood
vessels and vascular smooth muscle cells have been shown to pro-
duce IGF-1. Intracerebroventricular injection of IGF-1 in old rats
was able to restore object recognition in these rats (Markowska
et al., 1998). IGF-1 levels are low at birth and increase to the age
of 20 years, thereafter declining gradually. Peripheral administra-
tion of IGF-1 can increase the number of newborn neurons as
shown by an increased number of bromodeoxyuridine-positive
cells in the DG of rats (Aberg et al., 2000). It appears that the
peripheral release of IGF-1 is an important factor in inducing
cell proliferation in the DG since chronic infusion of anti-IGF-
1 antibody prevented the positive effects of treadmill running in
rats (Trejo et al., 2001). Importantly, intra-carotid injection of
IGF-1 in rats has been shown to increase BDNF gene expression
in the hippocampus of these animals (Carro et al., 2000). IFG-1
null mice show a significant reduction in the number of dentate
granule cells (DGCs) in the hippocampus (Beck and Hefti, 1995).
These mice showed a significant reduction in the number of
neurons in CA regions and DGCs in the DG. However, cholinergic
neurons in the medial septum and dopaminergic neurons in the
striatum remained unchanged (Beck and Hefti, 1995). All mice
lacking IGF-1 receptors and a majority of IGF-1 null mice die
at birth. Deleting IGF-1 in the liver has made an opportunity to
study the effects of peripheral IGF-1. Pappalysin1 is an enzyme
that cleaves IGF-1 bound IGF binding protein 4. Deletion of
the encoding gene, Pappa, decreases IGF-1 due to an increased
abundance of IFFBP4 leading to a significant reduction in body
weight and longevity. Multiple large-scale studies in humans have
shown that serum levels of IGF-1 are correlated with fitness and
as well as body mass indices (Poehlman and Copeland, 1990).
Furthermore, animal studies have shown that exercise in rats is
associated with increased amounts of IGF-1 in the CSF. IGF-1 acts
on muscles by stimulation of amino acid and peripheral glucose
uptake helping to maintain skeletal muscle mass.
Peroxisome proliferator-activated receptor-gamma coactivator
protein-1α
Peroxisome proliferator-activated receptor-gamma coactivator
protein-1alpha (PGC-1α) is a transcriptional co-activator of
mitochondrial biogenesis and oxidative metabolism in brown fat
(Spiegelman, 2007). Pgc-1α mRNA has been shown to be highly
expressed in the heart, skeletal muscle, and kidney, and to a lesser
degree in the liver, pancreas, and brain (Esterbauer et al., 1999).
PGC-1α has been shown to induce the activation of uncoupling
protein (UCP1) gene transcription. This factor is a member of the
UCP gene family and is solely expressed in brown adipose and is
involved in generating heat (Castillo-Quan, 2012).
Pgc-1α null mice develop spongiform neurodegeneration in
the striatum and deep layers of the cortex (Ma et al., 2010),
and this phenotype has been implicated in PD and Huntington
disease (Cui et al., 2006; St-Pierre et al., 2006; Tsunemi and La
Spada, 2012), strongly suggesting that PGC-1α plays a significant
role in maintaining neuronal function. Due to its role in mito-
chondrial biogenesis, it has been suggested that it might serve
as a neuroprotective agent. Indeed, it has been shown that Pgc-
1α knockout animals are more sensitive to 1-methyl-4-phenyl-
1,2,3,6-tetrahydropyridine toxicity than controls (St-Pierre et al.,
2006).
Since PGC-1α is a transcription factor with no ability to bind
to DNA, it has been suggested that it binds to nuclear receptor
estrogen-related receptor α (ERRα). This is supported by the fact
that physical activity leads to increased ERRα gene expression
in the brain (Wende et al., 2005). PGC-1α overexpression leads
to increased ERRα gene expression. Disruption of ERRα/PGC-
1α leads to reduced levels of FNDC5 gene expression. Knock-
ing down ERRα blocks PGC-1α induced Fndc5 gene expression
(Schreiber et al., 2003).
Recent studies have shown that Pgc-1α is synthesized in
muscle cells and induced by exercise and stimulates many of the
known markers of exercise in muscles including mitochondrial
biogenesis, angiogenesis and fiber-type switching. While chronic
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FIGURE 3 | The relationship between the total volume of the
hippocampus and age in met and non-met carriers. Using a polynomial
fitting curve, we found a significant correlation (r = −0.447, P = 0.0150)
between age and the volume of the hippocampus in met carriers. No such
correlation was found in non-met carriers (r = −0.178, P = 0.2639).
Furthermore, the slope of the regression in the hippocampal volume of met
carriers (slope = −0.038) was twice the value of the slope of regression in
non-met carriers (slope = −0.016; Published from Sanchez et al., 2011).
long-term treadmill running over 12 weeks leads to increase in
Pgc-1α gene expression in muscles, sedentary lifestyle has been
shown to be associated with reduced expression of this factor
(Handschin and Spiegelman, 2008). Notably, overexpression of
Pgc-1α in mice induced similar gene profiling in adipose tissue
that is caused by exercise (Boström et al., 2012).
Fibronectin type III domain containing 5
Fibronectin type III domain containing 5 (FNDC5) is a PGC-
1α-dependent myokine that is released during exercise (Boström
et al., 2012). FNDC5 is a type 1 transmembrane protein with
3 domains including a transmembrane hydrophobic domain, a
94 aa fibronectin 3 domain, and a signal peptide. Cleavage of
FNDC5 by a proteolytic enzyme generates a 12 kDa peptide called
irisin (Novelle et al., 2013). Following release, irisin (proteolytic
hormone derivative (myokine)) activates oxygen consumption
and thermogenesis in fat cells. PGC1α induces the formation of
FNDC5 in muscles. For this reason, overexpression of Pgc1α leads
to increased production of FNDC5, whereas reduced expression
of PGC1α by knocking out the gene leads to reduced production
of FNDC5. For example, adenovirus-mediated irisin overexpres-
sion can convert white subcutaneous fat into brown fat and, thus,
improve energy expenditure (see Figure 4).
In rodents’ brain, Fndc5 mRNA has been found primarily in
the midbrain, pons, cerebellum, and olfactory bulb. Additionally,
very low amounts of Fndc5 mRNA can be found in the hippocam-
pus. In the periphery, irisin immunoreactivity has been found in
skeletal muscles (all types of muscle fibers) and cardiomyocytes.
While in the CNS, irisin immunoreactivity has been only found in
GABA-ergic purkinje cells in the cerebellum and vestibular nuclei
of medulla oblongata, Fndc5 mRNA has been found extensively in
the brain of rodents (Ferrer-Martinez et al., 2002). The fact that
FNDC5 immunoreactivity has only been found in the purkinje
neurons of rodent brains (Dun et al., 2013) suggests that further
investigation into the translation or fate of FNDC5 mRNA is
warranted. As for the function of FNDC5, it appears that this
molecule is involved in dendritic spine formation (Cheng et al.,
2012).
Lecker et al. (2012) found a significant positive correlation
between Fndc5 gene expression in muscles and that of PGC-1α.
Furthermore, physical activity led to increase gene expression for
FNDC5 in muscles.
Recently, it was shown that exercise induces Fndc5 gene expres-
sion in muscles, and in turn, increases levels of irisin in the
circulation. Similarly, exercise leads to increased levels of both
FNDC5 and irisin in circulation (Huh et al., 2012; Lecker et al.,
2012). Accordingly, it has been shown that endurance exercise
leads to increase expression of Fndc5 in the hippocampus (Wrann
et al., 2013).
The exact role of FNDC5 is yet to be fully understood,
but it has been shown that it leads to a significant increase in
BDNF gene expression in cortical cell cultures. IV injection of
FNDC5 in mice leads to a significant increase in the BDNF gene
expression in the hippocampus. Conversely, treating hippocampal
neurons with BDNF reduces FNDC5 gene expression. A positive
correlation exists between FNDC5 and BDNF gene expression
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FIGURE 4 | Schematic representation of mechanisms by which increased
physical activity leads to improved cognitive function. The figure depicts
the two compartments alongside the blood brain barrier and the bidirectional
relationship of BNDF between central and peripheral compartments. For
instance, muscles, liver, and immune cells in the periphery impose a
significant influence on the brain, particularly on the DG of the hippocampus.
Conversely, BDNF has the ability to easily cross the BBB and influence
multiple mechanisms in the periphery. The fact that TrkB receptors have been
found in the spinal cord, DRGs, muscles, intestines, and kidneys suggests
that BDNF can exert multiple regulatory effects on both sides of the BBB.
Through co-activation of PGC1α and ERRα, physical activity induces the
production of FNCD5. Following cleavage by a protease, FNDC5 is cleaved
into irisin, which has the ability to cross the BBB and induce BDNF gene
expression in the hippocampus. Notably, it has also been shown that high
concentrations of IGF-1 are released by the liver and can, in turn, improve
neurogenesis in the DG and induce BDNF gene expression.
(Wrann et al., 2013). Accordingly, increases in FNDC5 expression
in the liver lead to increased levels of BDNF mRNA levels in the
hippocampus (Wrann et al., 2013). However, direct application
of irisin to cultured hippocampal neurons did not increase BDNF
gene expression suggesting that FNDC5 might have another
cleavage product (other than irisin) that can induce BDNF gene
expression (Xu and Heilshorn, 2013).
PUTATIVE EFFECTS OF EXTREME PHYSICAL ACTIVITY ON
THE BRAIN AND COGNITIVE FUNCTION
Despite the positive effects of moderate physical activity on the
brain, a number of studies have linked extreme exercise to disrup-
tion of cellular, metabolic, and hormonal processes and, in turn,
to adverse neurological sequelae and cognitive dysfunction. Here,
we review cellular mechanisms by which extreme physical activity
might interfere with normal neuronal function, particularly those
involved in learning and memory.
INCREASED REACTIVE OXYGEN SPECIES AND CYTOKINE PRODUCTION
The brain comprises approximately 2% of adult human body
weight and yet consumes approximately 20% of oxygen at rest
(Allaman, 2013). The high rate of oxygen consumption, coupled
with the low levels of anti-oxidant enzymes found in the brain,
particularly during intense levels of physical activity, increases
the vulnerability of the CNS to oxidative stress (Uttara et al.,
2009). It has been shown that extreme levels of physical activity
generate high levels of reactive oxygen species (ROS), lead-
ing to oxidative damage to DNA, RNA, proteins, and lipids
(Aguiló et al., 2005). Tsakiris et al. (2006) demonstrated that
prolonged forced swimming induced increased levels of ROS
in rats (Tsakiris et al., 2006). It has been demonstrated that
intense physical activity results in oxidative stress in rodents as
shown by a significant increase in brain glutathione peroxidase
(Hara et al., 1997) and lipid peroxidation (Somani and Husain,
1996). Moreover, Rosa et al. (2007) demonstrated young adult
mice undergoing 10 days of intense and exhaustive running
program exhibited a high index of brain oxidative stress and
impaired memory as assessed by fear conditioning. Recapitulating
these effects in humans, Aguiló et al. (2005) demonstrated that
intense mountain exercise leads to the generation of oxidative
stress and high levels of ROS. While vitamin E, an essential
anti-oxidant, typically inhibits the production of ROS during
lipid peroxidation, intense physical activity in humans leads to a
significant increase in vitamin E turnover that weakens antioxi-
dant defence (Mastaloudis et al., 2001). Thus, although moderate
levels of physical activity can enhance the antioxidant defence
mechanisms, extreme levels of physical activity can deplete anti-
oxidant reserve (Mastaloudis et al., 2001), leading to adverse
neurological effects (Gomez-Cabrera et al., 2008). Alternatively,
cytokines may modulate the negative effects of extreme physical
activity. IL-6 is directly released by muscles during physical
activity and activates the release of adrenocorticotropic hormone
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(ACTH) from the pituitary gland and increases cortisol levels
(Mastorakos et al., 2005). Together, these studies suggest that
extreme levels of physical activities may weaken the immune
system either by reducing anti-oxidant defence or by altering
cortisol levels.
INCREASED CORTICOSTEROID SIGNALING
Cortisol is a glucocorticoid (GC) that is released from the adrenal
gland in response to stress (Kudielka et al., 2009). The release
of cortisol from the adrenal gland is regulated by the release of
ACTH from the pituitary gland. Under physiological conditions,
cortisol, in conjunction with epinephrine and norepinephrine,
prepares an individual for the “fight or flight response”, enabling
rapid shifting of blood flow toward large skeletal muscles and
permitting an individual to flee threatening situations. Cortisol
also plays a significant role in memory processes (Tollenaar
et al., 2009), with areas of the brain important for memory (e.g.,
hippocampus, prefrontal cortex, amygdala) expressing high levels
of GC receptors (Ramos and Arnsten, 2007). In the hippocampal
region, excessive GCs levels have been linked to a significant
reduction in neurogenesis (Liu et al., 2003), suppression of
LTP in excitatory synapses (Setiawan et al., 2007), cell death
through apoptosis (Zhao et al., 2007), and extensive dendritic re-
organization in the prefrontal cortex (Cook and Wellman, 2004).
Historically, it has been assumed that physical activity lowers
GC levels and attenuates the adverse effects of stress (Cornil et al.,
1965); however, more recent evidence suggests the positive effects
of physical activity peak at upper-middle intensity levels (Soya
et al., 2011), with intense levels of physical activity being asso-
ciated with adverse effects (Tomporowski, 2003; Taverniers et al.,
2010, 2013). Indeed, it has been shown that the magnitude of cor-
tisol response is both positively and linearly related to the intensity
and duration of physical activity (Jacks et al., 2002; Tauler et al.,
2014). Similarly, elevated levels of ACTH have been detected in the
circulation after extreme exercise (plasma adrenocorticotropin
and cortisol responses to submaximal and exhaustive exercise).
It has been showed that both extreme physical activity paired
with psychological stress is linked to concomitant increases in
cortisol and impaired memory (Tomporowski, 2003; Taverniers
et al., 2010, 2013).
LESSONS FOR INTERVENTION
While the interactions between mind, brain, and body have
been conjectured for centuries, only recently have we begun to
understand the putative molecular mechanisms of such a rela-
tionship. Ratification of the positive benefits of physical activity
are now evident in studies demonstrating that increased physical
activity can significantly improve longevity (Bronnum-Hansen
et al., 2007), decrease the incidence of multiple chronic disorders
(Mokdad et al., 2004; Goodwin, 2008; Arida et al., 2009) and
delay age-related degeneration of brain tissue (Colcombe et al.,
2003). These benefits appear to be enhanced during times of high
cognitive demand, stress, and illness.
Also drawing increased attention in recent years is the positive
role that physical activity plays in increasing learning and memory
(van Praag et al., 1999). A meta-analysis of 18 longitudinal studies
has revealed that physical activity improved overall cognitive
function in humans (Vaynman et al., 2006). Moreover, it has been
demonstrated that physical activity can ameliorate the effect of
neurological diseases characterized by cognitive deficits, partic-
ularly in AD, PD, and psychiatric illnesses such as depression
and schizophrenia (Rolland et al., 2007). For example, BDNF
gene expression levels are commonly reduced in the normal aging
population and in people with AD (Phillips et al., 1991); yet
increased levels of physical activity appear to restore BDNF to
basal levels and, in turn, improve cognitive function in the aging
(Laurin et al., 2001) and AD patients (Lautenschlager et al., 2008).
In the CNS, exercise has been shown to increase adult neuro-
genesis in the DG of the hippocampus, improve dendritic com-
plexity and synaptic plasticity in the perforant path that carries
information from the entorhinal cortex to the DG (Eadie et al.,
2005), and increase angiogenesis. All these effects can be achieved
through the improved release and signaling of neurotrophins,
particularly BDNF. Scharfman et al. (2005) have demonstrated
that BDNF administration into the DG increases angiogenesis.
Similarly Tg2576 mouse models of AD show increased levels of
IL-1β and TNF in the hippocampus compared with controls.
IL-1β was found to be elevated in AD patients compared with
controls (Alvarez et al., 1996). Notably, this cytokine can increase
APP gene expression and protein (Griffin et al., 2006). Three
weeks of physical activity improved cognitive function as assessed
in Morris Water maze in mice, and reduced the brain expression
of pro-appoptic factors like caspase-9, caspase-3 and Bax and
increased the expression of anti-apoptotic factors like Bcl-2 in
these mice.
At the interface of physical activity and enhanced cogni-
tive function are NTs, particularly BDNF. BDNF is upregulated
following physical activity, with approximately 70–80% of the
additional expression derived centrally. Notably, activity-induced
upregulation of BDNF has been found primarily in the hip-
pocampus, a brain region critically important for learning and
memory.
The questions that have been raised are on the nature of
specificity and on the increase in BDNF gene expression in the
hippocampus. A number of studies have indicated that physical
activity causes a significant increase in BDNF gene expression
most robustly in the hippocampus (Cotman et al., 2007). This
may suggest that hippocampal neurons particularly DGCs have
receptors that would bind to a yet to be identified factor that
is released in the periphery to connect physical activity at the
periphery to gene expression as well as function in the CNS,
particularly the hippocampus. The fact that FNDC5 injected sys-
temically causes increased BDNF expression in the hippocampus
while treating cultured hippocampal neurons with this com-
pound does not induce BDNF gene expression in these cells
support this notion (Wrann et al., 2013). The DG region of the
hippocampus is one of the most vulnerable regions to aging and
neurodegeneration. However, this region is one of the few regions
that retain neurogenesis capabilities in adulthood, a process that
is significantly enhanced by exercise.
As we showed here (Sanchez et al., 2011), val2met polymor-
phism in the pro-domain of BDNF predicts the rate of failure
in skill task performance and the volume of the hippocampus in
healthy individuals. Multiple studies have shown that met carriers
Frontiers in Cellular Neuroscience www.frontiersin.org June 2014 | Volume 8 | Article 170 | 10
Phillips et al. Physical activity and neurotrophin signaling
show a significant reduction in the amount of BDNF released
during activity. Both BDNF and IGF-1 play a significant role
in cognition and motor function in humans. For these reasons,
the effects of genetic variations on physical activity must be
taken into consideration in any clinical trial, as polymorphisms
modulate the individualized response to physical activity. Ques-
tions regarding the role of genetic influences on the association
between response to physical activity and cognitive function
remain. Testing for genetic and environmental factors may be
important because cognitive decline appears to be highly heritable
and physical activity levels seem to be influenced by both factors
(e.g., socioeconomic status, nutrition, demographic).
Moreover, a better understanding of the relationship between
genetic profiles and distinct response to illness will permit health
care professionals to prescribe individualized exercise regimens
according to genetic profile. Such would enable the diagnosis and
treatment of an individual’s personal response to aging and illness
(Booth and Laye, 2009). For example, it has been shown that
val66met substitution reduces the excitability of primary motor
cortex following a repetitive motor task compared with val66val
individuals (Kleim et al., 2006). People with depression show
diminished levels of BDNF in their serum (Huang et al., 2008).
It has been shown that the use of repetitive transcranial magnetic
stimulation (rTMS) in depression can be linked to increased
BDNF levels (Zanardini et al., 2006), and yet met carriers appear
to be significantly less responsive to this procedure (Bocchio-
Chiavetto et al., 2008). Expanded use of rTMS in the clinical
setting and the potential ability of this technology to induce BDNF
expression suggest a means to improve BDNF levels in individuals
whose physical limitations avert participation in physical activity.
The identification of irisin suggests new avenues for phar-
macological intervention. It has been shown that IV adminis-
tration of irisin increases BDNF in mice, a potential treatment
for improved BDNF levels in those individuals who because of
physical impairments cannot participate in physical activity.
Plasma BDNF measures are highly variable between individ-
uals. Thus, meaningful studies must account for age, gender,
ethnicity, body weight (Komori et al., 2006), and activity level.
A key area of future research will be to refine cognitive
studies so as to investigate the genetically determined person-
alized response to physical activity to increase relevance and
translatability to humans. Uncovering the molecular and cellular
linkages between physical activity and cognition is critical to
advancements in studies of aging and neurodegeneration. A better
understanding of these mechanisms will enable the development
of pharmaceuticals, particularly for those who are activity limited
(coma, spinal cord injury, etc.). Moreover, a better understanding
will permit healthcare professionals to provide individualized
prescriptions for patients after considering their genetic and pro-
teomic profiles, both of which determine an individual’s personal
response to aging and illness (Booth and Laye, 2009).
CONCLUSIONS
There is an urgent need to develop pharmacological and non-
pharmacological methods to improve the status of neurons
and their dendritic terminals given the increase in individuals
affected by neurodegenerative disorders. Physical activity offers
an affordable and effective method to improve cognitive function
in all ages, particularly the elderly who are most vulnerable to
neurodegenerative disorders. The dual effects of chronic and acute
physical activity on inflammatory processes, particularly in those
individuals with an underlying inflammatory condition, must
be better understood such that the nature of physical activity
and its inducing health benefits can be harnessed for therapeutic
purposes in vulnerable populations.
Further refinement of the mechanisms by which myokines
are released by peripheral muscles during exercise could improve
our understanding of mechanisms of BDNF synthesis by the
DG and could potentially lead to the identification of new
and therapeutically-important factors that mediate these effects.
Moreover, since the majority of BDNF synthesis occurs in the
hippocampus, there might be new technologies developed in the
future to quantify the release of BDNF from the brain and not
in whole circulation. The availability of novel nanotechnological
methods to collect blood samples locally at the cellular level
would refine further knowledge about the type and intensity of
physical activities that induce BDNF synthesis in the brain (Song
et al., 2012). Expansion of the use of new and high throughput
DNA sequencing systems would facilitate better the study of the
effects of different polymorphisms, particularly val2met in the
BDNF gene. Having access to information regarding one’s genetic
profile and individualized response to exercise would constitute
the first steps toward achieving our primary goal of delivering
personalized medicine.
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